NASPCC Upcoming Webinar Series

NASPCC Presents:

“PSMA Imaging in Prostate Cancer: New Developments”

With Dr. Michael Morris, Clinical Director, Memorial Sloan-Kettering Cancer Center in New York

Thursday, October 1, 2020
7:00 pm – 8:00 pm Eastern

About the Presenter

dr michael morrisDr. Michael Morris is prostate cancer specialist, clinical investigator, and the Section Head of Prostate Cancer of the Genitourinary Oncology Service at Memorial Sloan-Kettering Cancer Center. He earned his medical degree from the Mount Sinai School of Medicine in New York, and performed his internship and residency in Internal Medicine at Columbia Presbyterian Medical Center. He then completed his medical oncology fellowship at Memorial Sloan-Kettering Cancer Center, where he was the Chief Fellow as well.

Dr. Morris has led numerous clinical trials, but he has a particular research focus on targeted therapy for prostate cancer, especially those that bridge the fields of Medical Oncology and Nuclear Medicine. In the field of therapeutics, he has focused on radio immunotherapy and other radio-conjugates, bone directed therapy, and other targeted therapies. In the field of diagnostics, he has a keen research interest in developing novel imaging technologies for metastatic prostate cancer and in developing novel imaging biomarkers. He has been a co-developer of the Prostate Cancer Working Group 2 and 3 Consensus Criteria, and novel prostate-specific imaging technologies such as FDHT PET and PSMA-directed PET imaging.

In addition, he is the Medical Director of the Department of Prostate Cancer Clinical Consortium, and chairs the GU Committee of the Alliance for Oncology Trials in Oncology (formerly CALGB).

Registration

Use this link to register for this webinar>>

Sponsor

This Webinar is sponsored by: Progenics Pharmaceuticals

Progenics Pharmaceuticals: Find Fight and Follow 

Archived Webinars

Please use this link to view NASPCC's archived webinars...

 

 

 

Gala Dinner at the 15th

"Participate, Educate, Celebrate"

NASPCC logo with 15th AnniversaryThe National Alliance of State Prostate Cancer Coalitions – “The Prostate Cancer Alliance”- is pleased to present its 15th Annual Meeting GALA on Saturday, October 19, 2019 at 6:30 pm.

Cocktails and Dinner will be provided, along with an evening of celebration, honoring Paul Schellhammer, M.D., and others, and also featuring James Gulley, MD, PhD of NIH in his third appearance at the Annual Meetings held by the Prostate Cancer Alliance.

Tickets for guests (non-state representatives) are available at $100 per person, and additional donations are welcome. For information please contact Merel Nissenberg at This email address is being protected from spambots. You need JavaScript enabled to view it..

Use this link to download the invitation flyer (PDF)...

Attachments:
Download this file (InvitationGALA15th.pdf)InvitationGALA15th.pdf[Gala Dinner invite]359 kB

Patient Conference on Prostate Cancer

POSTPONED

Second Annual Patient Conference on Prostate Cancer

June 6, 2020, 8:00 am – 5:00 pm

Location TBA

The Steering Committee has decided to postpone this event until early Fall. We will post the new date here as soon as it is available. 

The day-long event will be held in the San Francisco Bay Area, at a venue to be announced. Co-sponsored by The California Prostate Cancer Coalition (CPCC) and The UCSF Helen Diller Family Comprehensive Cancer Center

 

Last year's conference...

The 2019 Patient Cancer Conference on Prostate Cancer

"Using Current and Cutting-Edge Information to Help Make Informed Decisions"

June 8, 2019

The California Prostate Cancer Coalition (CPCC) and the Helen Diller Family Comprehensive Cancer Center of UCSF proudly presented The 2019 Patient Conference on Prostate Cancer in Cole Hall on the UCSF Campus, in San Francisco, on Saturday, June 8, 2019. The conference was for patients, caregivers, health care providers and all those interested in information and tools to make informed decisions in prostate cancer.

A stellar faculty included Eric Small, MD; Peter Carroll, MD, MPH; Matt Cooperberg, MD, MPH; Mack Roach III, MD; Felix Feng, MD; Rahul Aggarwal, MD; June Chan, ScD; Leonard Marks, MD; Joseph Scherger, MD, MPH, Thomas Hope, MD, and many others presented during the day-long Conference.

Use this link to access the archived recordings of the sessions

 

Topics included:

  • Prostate Cancer Basics
  • Genetics and Genomics
  • Immunology
  • Clinical Trials
  • ABCs of Androgen Deprivation Therapy
  • Low-Risk Disease and Active Surveillance
  • Treatment of Metastatic and Non-Metastatic Disease
  • Systemic Therapy
  • Imaging
  • Diet and Exercise
  • Managing Side Effects, Access to Care
  • Intimacy and Sexual Function

Effective Shared Decision-Making requires that the patient and his doctor be INFORMED in order to make the best decisions. This Conference will help patients become informed so that they can think about their care, discuss their case with their doctors and others, and join in effective informed decision-making.

See links to Conference agenda, flyer and program below.

 

California Prostate Cancer Coalition

Helen Diller Family Comprehensive Cancer Center

 

 

Attachments:
Download this file (AgendaCPCC-UCSF-Final.pdf)Conference Agenda[ ]105 kB
Download this file (CPCCUCSF-2019Program.pdf)CPCCUCSF-2019Program.pdf[2019 Conf Brochure - PDF]1333 kB
Download this file (Flyer-PC-Conf-June-2019.pdf)PC Conference Flyer[ ]293 kB

15th Annual NASPCC Meeting and Gala

National Alliance of State Prostate Cancer Coalitions

Report from the 15th Annual Meeting and Gala

naspcc logo jpeg

October 18, 2019 – October 20, 2019
Hotel Monaco, Washington, D.C.

“Educate, Participate, Celebrate”

The 15th Annual Meeting & Gala of the National Alliance of State Prostate Cancer Coalitions, also known as The Prostate Cancer Alliance, was held at the esteemed Hotel Monaco in Washington, D.C. on the site of the original General Post Office Building (circa 1840), from Friday, October 18, 2019 through 3:00 p.m. on Sunday, October 20, 2019.

This was a celebratory Annual Meeting, as it was a landmark year – our 15th year of helping prostate cancer patients and their families. State prostate cancer organizations – coalitions, foundations, associations and other entities - from across the entire United States, including Alaska and Hawaii, sent at least one, sometimes two or three representatives to the 15th Annual Meeting.

The expectation as always was that at the conclusion of the Annual Meeting, all attendees would return to their respective constituencies and then disseminate throughout their states, all of the educational, scientific and practical information they’d received, thereby helping patients everywhere. 

Annual Meeting Sponsors sent representatives to the 15th Annual Meeting & Gala to learn, to network and to work with state prostate cancer organizations, as well as to distribute their materials. There were a record 16 sponsors for this year’s event, and NASPCC is very grateful for their support which helped us to organize and hold this stellar Annual Meeting.

Save the Date

Save the date for NASPCC’s 16th Annual Meeting. The meeting will take place January 29-31, 2021 at the Hotel Monaco in Washington, DC. Please contact This email address is being protected from spambots. You need JavaScript enabled to view it.  for details.

 

15th Annual Meeting Proceedings

Conference Presentation Files

All files are in PDF format that may require a plugin for viewing.

1a - Prostate Cancer: The Basics - Vincent P. Laudone, M.D.

1 - Arkansas Prostate Cancer Foundation Best Practices - Bev Eckert, Chris Collier

2 - From Academia to Community Care: Lessons Learned and Considerations for Delivering Excellent Care - Ashley E. Ross, M.D., Ph.D.

2a -Prostate Cancer Genetics 100 - Leonard G. Gomella, MD

3 -Prostate Cancer Treatment In A Community Setting - Gregory J Gagnon, M.D.

3a -Immunotherapy in Prostate Cancer - Adam R. Metwalli, MD

4 - Cancer Care - Dr. Goren

4a - Demystifying Clinical Trials: Focusing on Trials with Therapeutic Intent - Ashley E. Ross MD PhD

5 - Managing The Effects of Prostate Cancer Treatment - Krishnan Venkatesan

5a - ABCs of Androgen Deprivation Therapy (ADT) - Jeanny B. Aragon-Ching, M.D., F.A.C.P

6 - Prostate Cancer and African American Men - Judd W. Moul, M.D. FACS

7 - Prostate Cancer: Disease Localization and Risk Stratification - Vincent P. Laudone, M.D.

8 - Dawn of New Era for Prostate Cancer Patients - Asha Das, MD

9 - Prostate Cancer: Active Surveillance - Vincent P. Laudone, M.D.

10 - Low Risk Localized Prostate Cancer Panel: Genomic Tests - Judd W. Moul, M.D. FACS

11 - Focal therapy for prostate cancer - Daniel Song MD

12 - Multimodality Therapy for High Risk Disease – The Surgical Perspective - Vincent P. Laudone, M.D.

13 - Intermediate, High Risk and Oligometastatic Disease: Radiation Options - Dr Jeff Skinner

14 - Prostate Cancer and Non-Metastatic Castration-Resistant Prostate Cancer - Germino

15 - The Optimal Treatment of Bone Metastases - Philip Saylor, M.D.

16 - New and Developing Treatment Approaches for Patients with Non-Localized Prostate Cancer - Markowski

17 - PSA/Biochemical Recurrence of Prostate Cancer - Judd W. Moul, M.D., F.A.C.S.

18 - The Role of Nutrition and Lifestyle in Addressing Prostate Cancer - Joseph E. Scherger, MD, MPH

 

Attachments:
Download this file (Invitation15thMeetingGala.pdf)Invitation15thMeetingGala.pdf[Invitation to Gala Dinner and Meeting]379 kB
Download this file (Program2019Oct15qxp.pdf)Conference Program - PDF[ ]1047 kB

Presentations from the 14th Annual Meeting

Here are some presentations from the NASPCC 14th Annual Meeting.

Use the links below to download the PowerPoint presentation slides for each presentation. Files in PDF are so indicated. A plugin or additional software is required to view this content.

  1. The Importance of Hereditary Cancer Testing in Prostate Cancer - Rob Finch, MS, CGC
  2. Genomics and Prostate Cancer - Cecilia Hammond, MSN
  3. Genomic Testing: When and Why? - Rob Finch, MS, CGC
  4. Why Nuclear AR-V7 - Katherine Atkinson
  5. Active Surveillance for Low Risk Prostate Cancer - Michael A. Gorin, M.D.
  6. THE DISEASE LANDSCAPE OF PROSTATE CANCER (PDF) - Nicholas Souders, Ph.D.
  7. Chemotherapy Options for Advanced Prostate Cancer - Jeanny B. Aragon-Ching, M.D., F.A.C.P.
  8. Bone Scan Index as a Prognostic Biomarker (PDF) - Karl Sjöstrand, PhD
  9. 2018 UPDATE ON IMMUNOTHERAPY IN PROSTATE CANCER - James L. Gulley, M.D., Ph.D., F.A.C.P.
  10. Radiation Therapy for Prostate Cancer - Ronald Chen, MD MPH
  11. Patient-specific Treatment of Prostate Cancer - Shyam Natarajan, PhD
  12. Space OAR Hydrogel - April Renzella
  13. Positron Emission Tomography For Evaluation of Prostate Cancer - Eugene D Kwon MD
  14. FDA Approvals for Systemic Treatment of Prostate Cancer in 2018 - William R Berry MD
  15. ADVANCED PROSTATE CANCER: BONE ISSUES AND METASTASES - Samuel Denmeade, MD